Articles
-
1 month ago |
cellandgene.com | Erin Harris |Todd Andrews |James Calle |Matt Dean
Webinar: Advanced Contamination Control for Cell Therapy: Automation, Assays, and Process EfficiencyThis webinar explores contamination control in cell therapy manufacturing, focusing on automated closed systems, larger bioprocess containers, and rapid analytical assays. It highlights how these tools enhance sterility, efficiency, and product quality. Experts Alexandra Lisi and Sandi True will share insights into integrating these solutions for improved operational effectiveness.
-
1 month ago |
cellandgene.com | Erin Harris
By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 During our most recent Cell & Gene Live, Unlocking the Potential of iPSC Therapies in Regenerative Medicine, I had the privilege of moderating a conversation with two pioneering leaders shaping the future of regenerative medicine: Julie Allickson, Ph.D., Chief Technology Officer at Mayo Clinic's Center for Regenerative Biotherapeutics and Erin Kimbrel, Ph.D., Head of Cell & Gene Therapy Research at Astellas.
-
1 month ago |
cellandgene.com | Erin Harris
By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 As gene therapy continues to redefine what’s possible in the treatment of serious diseases, the commercial challenges that accompany this modality are becoming just as critical to address as the science itself.
-
1 month ago |
cellandgene.com | Erin Harris
By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 While the CGT sector has made significant strides in oncology, its transformative potential extends well beyond cancer. A growing number of companies are advancing CGT approaches for rare and inherited diseases, including those affecting vision.
-
1 month ago |
cellandgene.com | Erin Harris
Discover the future of iPSC-based therapies in this free Cell & Gene Live digital event. Experts will share insights on emerging applications, regulatory challenges, gene editing advancements, and key safety considerations in scalable iPSC manufacturing. Don't miss this opportunity to hear from leaders at the forefront of regenerative medicine. Supported by Invetech.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 960
- Tweets
- 1K
- DMs Open
- No
RT @_CellandGene: On #CellAndGenePodcast, @ArrowheadPharma CMO Javier San Martin shares the roadmap for #RNAi as well as the company's pipe…
RT @_CellandGene: CGT manufacturers that deprioritize cybersecurity efforts risk their ecosystem being vulnerable to cyber-attacks that can…
RT @_CellandGene: Walter Strapps, CEO of @Carver_Bio states that when it comes to #mRNA, the challenges associated with its delivery are an…